Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,814,086
-
Share change
-
+2,918,241
-
Total reported value
-
$5,521,000
-
Price per share
-
$0.95
-
Number of holders
-
16
-
Value change
-
+$2,886,929
-
Number of buys
-
11
-
Number of sells
-
6
Institutional Holders of NOVUS THERAPEUTICS INC - COM (NVUS) as of Q3 2020
As of 30 Sep 2020,
NOVUS THERAPEUTICS INC - COM (NVUS) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,814,086 shares.
The largest 10 holders included
BVF INC/IL, Asymmetry Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, VANGUARD GROUP INC, Thrivent Financial for Lutherans, BANK OF AMERICA CORP /DE/, Rockefeller Capital Management L.P., NORTHERN TRUST CORP, and Tower Research Capital LLC (TRC).
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.